KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Prepaid Assets (2016 - 2025)

Nektar Therapeutics has reported Prepaid Assets over the past 16 years, most recently at $20.5 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $20.5 million for Q4 2025, up 238.18% from a year ago — trailing twelve months through Dec 2025 was $20.5 million (up 238.18% YoY), and the annual figure for FY2025 was $20.5 million, up 238.18%.
  • Prepaid Assets for Q4 2025 was $20.5 million at Nektar Therapeutics, up from $11.1 million in the prior quarter.
  • Over the last five years, Prepaid Assets for NKTR hit a ceiling of $23.3 million in Q4 2021 and a floor of $6.1 million in Q4 2024.
  • Median Prepaid Assets over the past 5 years was $11.2 million (2025), compared with a mean of $13.9 million.
  • Biggest five-year swings in Prepaid Assets: tumbled 66.65% in 2021 and later skyrocketed 238.18% in 2025.
  • Nektar Therapeutics' Prepaid Assets stood at $23.3 million in 2021, then plummeted by 32.25% to $15.8 million in 2022, then crashed by 38.14% to $9.8 million in 2023, then plummeted by 37.97% to $6.1 million in 2024, then skyrocketed by 238.18% to $20.5 million in 2025.
  • The last three reported values for Prepaid Assets were $20.5 million (Q4 2025), $11.1 million (Q3 2025), and $10.7 million (Q2 2025) per Business Quant data.